v. 28 – Q4 2023
| Market Executive Summary | Official statement: “As the national regulator of medicinal products, the NMRA has decided to implement a digital track and trace system to improve the safety, efficacy and quality of drugs, devices and borderline products available in the country.
Prior to such implementation, the NMRA wishes to study digital track and trace systems available in the market, their designs, usage, costing models and other related parameters by obtaining the required information from solution providers who would be consulted in the form of informal presentations and discussions.” |
| Key Dates | None |